Nomogram basing pre-treatment parameters predicting early response for locally advanced rectal cancer with neoadjuvant chemotherapy alone: a subgroup efficacy analysis of FOWARC study-Reference-Cited by-同舟云学术

Nomogram basing pre-treatment parameters predicting early response for locally advanced rectal cancer with neoadjuvant chemotherapy alone: a subgroup efficacy analysis of FOWARC study

Published:2015-12-04 Issue:4 Volume:7 Page:5053-5062
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Zhang Jianwei¹,Cai Yue¹,Hu Huabin¹,Lan Ping²,Wang Lei²,Huang Meijin²,Kang Liang²,Wu Xiaojian²,Wang Hui²,Ling Jiayu¹,Xiao Jian¹,Wang Jianping²,Deng Yanhong¹

Affiliation:

1. Department of Medical Oncology, The Sixth Affiliated Hospital of Sun-Yat Sen University, Guangzhou, Guangdong, P.R. China

2. Department of Colorectal Surgery, The Sixth Affiliated Hospital of Sun-Yat sen University, Guangzhou, Guangdong, P.R. China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A nomogram for predicting good response after neoadjuvant chemoradiotherapy for locally advanced rectal cancer: a retrospective, double-center, cohort study;International Journal of Colorectal Disease;2022-09-01

2. Clinico-pathological predictors of clinical complete response in rectal cancer;Cancer Treatment and Research Communications;2022

3. ERα promotes transcription of tumor suppressor gene ApoA-I by establishing H3K27ac-enriched chromatin microenvironment in breast cancer cells;Journal of Zhejiang University-SCIENCE B;2021-12

4. Early response to upfront neoadjuvant chemotherapy (CAPOX) alone in low- and intermediate-risk rectal cancer: a single-arm phase II trial;British Journal of Surgery;2021-11-18

5. Apolipoprotein A-I (ApoA-I), Immunity, Inflammation and Cancer;Cancers;2019-08-01